Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft first-quarter performance.